Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 21,648 | 30,688 | 33,805 | 27,382 | 31,543 |
| Operating Income | -21,648 | -30,688 | -33,805 | -27,382 | -31,543 |
| Interest Expense | 22 | 25 | 28 | 30 | 35 |
| Other Income | 1,387 | 4,610 | 1,177 | 1,488 | 2,089 |
| Pre-tax Income | -20,283 | -26,103 | -32,656 | -25,924 | -29,489 |
| Net Income Continuous | -20,283 | -26,103 | -32,656 | -25,924 | -29,489 |
| Net Income | $-20,283 | $-26,103 | $-32,656 | $-25,924 | $-29,489 |
| EPS Basic Total Ops | -0.33 | -0.60 | -0.99 | -0.79 | -0.89 |
| EPS Basic Continuous Ops | -0.33 | -0.60 | -0.99 | -0.78 | -0.89 |
| EPS Diluted Total Ops | -0.33 | -0.60 | -0.99 | -0.79 | -0.89 |
| EPS Diluted Continuous Ops | -0.33 | -0.60 | -0.99 | -0.78 | -0.89 |
| EPS Diluted Before Non-Recurring Items | -0.33 | -0.60 | -0.99 | -0.78 | -0.89 |
| EBITDA(a) | $-21,515 | $-30,580 | $-33,745 | $-27,307 | $-31,460 |